Osteoporosis management and the utilization of FRAX®: A survey amongst health care professionals of the Asia-Pacific

Archives of Osteoporosis

Volumn 7, Issue 1-2, 2012, Pages 193-200

  Korthoewer, Daniela ^a   Chandran, Manju ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Bone densitometry; FRAX ; Management practice; Osteoporosis; Southeast Asia

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; PARATHYROID HORMONE[1-34]; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STRONTIUM RANELATE;

ADULT; AGE DISTRIBUTION; ALGORITHM; ASIA; AWARENESS; BONE DENSITOMETRY; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG USE; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; FRACTURE RISK ASSESSMENT TOOL; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; MASS SCREENING; OSTEOPOROSIS; PACIFIC ISLANDS; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SECONDARY OSTEOPOROSIS; UNSPECIFIED SIDE EFFECT; VITAMIN D DEFICIENCY;

ADULT; AGED; ASIA; BONE DENSITY CONSERVATION AGENTS; DENSITOMETRY; FEMALE; HEALTH CARE SURVEYS; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OSTEOPOROSIS; PACIFIC ISLANDS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; RISK FACTORS; YOUNG ADULT;

EID: 84876286714     PISSN: 18623522     EISSN: 18623514     Source Type: Journal    
DOI: 10.1007/s11657-012-0097-9     Document Type: Review

References (32)

1. Borgström F, Zethraeus N, Johnell O et al (2006) Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporos Int 17(5):637-650. doi: 10.1007/s00198-005-0015-8
2. Cummings SR, Kelsey JL, Nevitt MC et al (1985) Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 7:178-208
3. Sanders KM, Nicholson GC, Ugoni AM et al (1999) Health burden of hip and other fractures in Australia beyond 2000. Projections based on the Geelong Osteoporosis Study. Med J Aust 170(10):467-470
4. Riggs BL, Melton L (1995) The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 17(5 Suppl):505S-511S
5. Kanis J (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359(9321):1929-1936. doi: 10.1016/S0140-6736(02)08761-5
6. Lau EM, Suriwongpaisal P, Lee JK et al (2001) Risk factors for hip fracture in Asian men and women: the Asian osteoporosis study. J Bone Miner Res 16(3):572-580. doi: 10.1359/jbmr.2001.16.3.572
7. Mithal A (2009) The Asian Audit. Epidemiology, costs and burden of osteoporosis in Asia 2009. www.iofbonehealth.com. Accessed 26 Mar 2012
8. Kanis JA, Johnell O, Oden A et al (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19(4):385-397. doi: 10.1007/s00198-007-0543-5
9. Tamaki J, Iki M, Kadowaki E et al (2011) Fracture risk prediction using FRAX(R): a 10-year follow-up survey of the Japanese Population-Based Osteoporosis (JPOS) Cohort Study. Osteoporos Int 22(12):3037-3045. doi: 10.1007/s00198-011-1537-x
10. World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO technical report series
11. Elliot-Gibson V, Bogoch ER, Jamal SA et al (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15(10):767-778. doi: 10.1007/s00198-004-1675-5
12. Cadarette S, Gignac M, Jaglal S et al (2007) Access to osteoporosis treatment is critically linked to access to dual-energy X-ray absorptiometry testing. Med Care 45(9):896-901. doi: 10.1097/MLR.0b013e318054689f
13. Abrahamsen B, Hansen TB, Jensen LB et al (1997) Site of osteodensitometry in perimenopausal women: correlation and limits of agreement between anatomic regions. J Bone Miner Res 12(9):1471-1479. doi: 10.1359/jbmr.1997.12.9.1471
14. Watts NB (2004) Fundamentals and pitfalls of bone densitometry using dual-energy X-ray absorptiometry (DXA). Osteoporos Int 15(11):847-854. doi: 10.1007/s00198-004-1681-7
15. Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporosis Int 4(6):368-381. doi: 10.1007/BF01622200
16. Hans D, Kanis J, Baim S et al (2011) Joint official positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX((R)). Executive summary of the 2010 Position Development Conference on Interpretation and use of FRAX(R) in clinical practice. J Clin Densitom 14(3):171-180. doi: 10.1016/j.jocd.2011.05.007
17. Lau EM, Lee JK, Suriwongpaisal P et al (2001) The incidence of hip fracture in four Asian countries: the Asian Osteoporosis Study (AOS). Osteoporos Int 12(3):239-243
18. Chandran M, Hoeck HC, Wong HC et al (2011) Vitamin D status and its relationship with bone mineral density and parathyroid hormone in Southeast Asian adults with low bone density. Endocr Pract 17(2):226-234. doi: 10.4158/EP10202.OR
19. Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22(4):477-501. doi: 10.1210/er.22.4.477
20. Lips P, Hosking D, Lippuner K et al (2006) The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 260(3):245-254. doi: 10.1111/j.1365-2796.2006.01685. x
21. National Osteoporosis Foundation (2010) Clinician's guide to prevention and treatment of osteoporosis. www.nof.org. Accessed 26 Mar 2012
22. Yung CK, Fook-Chong S, Chandran M (2012) The prevalence of recognized contributors to secondary osteoporosis in South East Asian men and post-menopausal women. Are Z score diagnostic thresholds useful predictors of their presence? Arch Osteoporos. doi: 10.1007/s11657-012-0078-z
23. Chan KH (2007) Clinical Management Guidelines for Osteoporosis in Hong Kong. www.oshk.org.hk/upload-files/files/OsteoporosismgtGuidelines2004.pdf. Accessed 28 May 2012
24. Li-Yu J, Perez E, Canete A et al (2011) Consensus statements on osteoporosis diagnosis, prevention, and management in the Philippines. Int J Rheum Dis 14(3):223-238. doi: 10.1111/j.1756-185X.2011.01626.x
25. Malaysian Osteoporosis Society (2006) Clinical Practice Guidelines on Management of Osteoporosis. www.acadmed.org.my/view-file.cfm?fileid=208. Accessed 28 May 2012
26. Thai Osteoporosis Foundation (2010) Osteoporosis management guidelines. http://www.topf.or.th/ckfinder/userfiles/files/topf-pdf/cpg-en2.pdf. Accessed 28 May 2012
27. National Institutes for Health and Clinical Excellence (2011) Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures inpostmenopausal women (amended) (NICE technology appraisal guidance 160). Accessed 28 May 2012
28. Salari P, Abdollahi M (2012) Long term bisphosphonate use in osteoporotic patients; a step forward, two steps back. J Pharm Pharm Sci 15(2):305-317
29. Chami G, Jeys L, Freudmann M et al (2006) Are osteoporotic fractures being adequately investigated? A questionnaire of GP & orthopaedic surgeons. BMC Fam Pract 7:7. doi: 10.1186/1471-2296-7-7
30. Chan SP, Scott BB, Sen SS (2010) An Asian viewpoint on the use of vitamin D and calcium in osteoporosis treatment: physician and patient attitudes and beliefs. BMC Musculoskelet Disord 11:248. doi: 10.1186/1471-2474-11-248
31. Lai MMY, Ang WM, McGuiness M et al (2012) Undertreatment of osteoporosis in regional Western Australia. Australas J Ageing 31(2):110-114. doi: 10.1111/j.1741-6612.2011.00544.x
32. Simonelli C, Killeen K, Mehle S et al (2002) Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons. Mayo Clin Proc 77(4):334-338. doi: 10.1016/S0025-6196(11)61786-2